Matches in SemOpenAlex for { <https://semopenalex.org/work/W2776268962> ?p ?o ?g. }
- W2776268962 endingPage "49" @default.
- W2776268962 startingPage "41" @default.
- W2776268962 abstract "Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia Monica C Robotin,1–3 Ximena Masgoret,1 Mamta Porwal,4 David Goldsbury,5 Chee Khoo,6,7 Jacob George,2,3 1School of Medicine, The University of Notre Dame Australia, Darlinghurst, 2Faculty of Medicine, University of Sydney, Camperdown, 3Storr Liver Center, Westmead Institute for Medical Research, Westmead Hospital, Westmead, 4Australian School of Graduate Management, University of New South Wales, Kensington, 5Cancer Council NSW, Woolloomooloo, 6Royal Australasian College of General Practitioners, Sydney, 7University of Western Sydney, Macarthur, NSW, Australia Background: Approximately 1% of Australians have chronic hepatitis B (CHB), which disproportionately affects people born in hepatitis B-endemic countries. Currently, approximately half of the people affected remain undiagnosed and antiviral treatment uptake is suboptimal (~5%). This increases the likelihood of developing end-stage disease complications, particularly hepatocellular cancer (HCC), and largely accounts for the significant increases in HCC incidence and mortality in Australia over the last decades. As our previous economic modeling suggested that CHB screening and treatment is cost-effective, we tested the feasibility of a primary care-based model of CHB diagnosis and management to prevent HCC.Materials and methods: From 2009 to 2016, the B Positive program trialed a CHB screening and management program in an area of high disease prevalence in Sydney, Australia. Trained local primary care providers (general practitioners) screened and managed their CHB patients using a purpose-built CHB Registry and a risk stratification algorithm, which allocated patients to ongoing primary care-based management or specialist referral.Results: The program enrolled and followed up >1,500 people (25% of the target population). Their median age was 48 years, with most participants being born in China (50%) or Vietnam (32%). The risk stratification algorithm allocated most Registry participants (n=847 or 79%) to primary care-based management, reducing unnecessary specialist referrals. The level of antiviral treatment uptake in Registry patients was 18%, which was the optimal level in this population group.Conclusion: This pilot program demonstrated that primary care-based hepatitis B diagnosis and management is acceptable to patients and their care providers and significantly increases compliance with treatment guidelines. This would suggest that scaling up access to hepatitis B treatment is achievable and can provide a means to operationalize a population-level approach to CHB management and liver cancer prevention. Keywords: hepatitis B Registry, primary care, cancer prevention, antiviral treatment, risk stratification" @default.
- W2776268962 created "2018-01-05" @default.
- W2776268962 creator A5011865871 @default.
- W2776268962 creator A5014476939 @default.
- W2776268962 creator A5030549626 @default.
- W2776268962 creator A5045895400 @default.
- W2776268962 creator A5060306242 @default.
- W2776268962 creator A5068626576 @default.
- W2776268962 date "2017-12-01" @default.
- W2776268962 modified "2023-10-16" @default.
- W2776268962 title "Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia" @default.
- W2776268962 cites W1822947686 @default.
- W2776268962 cites W1964619581 @default.
- W2776268962 cites W1970313647 @default.
- W2776268962 cites W1999867705 @default.
- W2776268962 cites W2000307707 @default.
- W2776268962 cites W2000449155 @default.
- W2776268962 cites W2001867747 @default.
- W2776268962 cites W2009796858 @default.
- W2776268962 cites W2018684537 @default.
- W2776268962 cites W2040562731 @default.
- W2776268962 cites W2051679473 @default.
- W2776268962 cites W2058199797 @default.
- W2776268962 cites W2075639088 @default.
- W2776268962 cites W2078197314 @default.
- W2776268962 cites W2087564721 @default.
- W2776268962 cites W2104389844 @default.
- W2776268962 cites W2104475038 @default.
- W2776268962 cites W2109646200 @default.
- W2776268962 cites W2110767513 @default.
- W2776268962 cites W2111492162 @default.
- W2776268962 cites W2119496945 @default.
- W2776268962 cites W2125065061 @default.
- W2776268962 cites W2126385668 @default.
- W2776268962 cites W2139377426 @default.
- W2776268962 cites W2159546804 @default.
- W2776268962 cites W2164357011 @default.
- W2776268962 cites W2164445538 @default.
- W2776268962 cites W2190976684 @default.
- W2776268962 cites W2291018699 @default.
- W2776268962 cites W4211026375 @default.
- W2776268962 doi "https://doi.org/10.2147/clep.s146275" @default.
- W2776268962 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5745153" @default.
- W2776268962 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29339926" @default.
- W2776268962 hasPublicationYear "2017" @default.
- W2776268962 type Work @default.
- W2776268962 sameAs 2776268962 @default.
- W2776268962 citedByCount "7" @default.
- W2776268962 countsByYear W27762689622019 @default.
- W2776268962 countsByYear W27762689622020 @default.
- W2776268962 countsByYear W27762689622021 @default.
- W2776268962 countsByYear W27762689622022 @default.
- W2776268962 countsByYear W27762689622023 @default.
- W2776268962 crossrefType "journal-article" @default.
- W2776268962 hasAuthorship W2776268962A5011865871 @default.
- W2776268962 hasAuthorship W2776268962A5014476939 @default.
- W2776268962 hasAuthorship W2776268962A5030549626 @default.
- W2776268962 hasAuthorship W2776268962A5045895400 @default.
- W2776268962 hasAuthorship W2776268962A5060306242 @default.
- W2776268962 hasAuthorship W2776268962A5068626576 @default.
- W2776268962 hasBestOaLocation W27762689621 @default.
- W2776268962 hasConcept C120665830 @default.
- W2776268962 hasConcept C121332964 @default.
- W2776268962 hasConcept C121608353 @default.
- W2776268962 hasConcept C126322002 @default.
- W2776268962 hasConcept C203014093 @default.
- W2776268962 hasConcept C2522874641 @default.
- W2776268962 hasConcept C2776231280 @default.
- W2776268962 hasConcept C2777075537 @default.
- W2776268962 hasConcept C2777214474 @default.
- W2776268962 hasConcept C2777382497 @default.
- W2776268962 hasConcept C2778527826 @default.
- W2776268962 hasConcept C2779102576 @default.
- W2776268962 hasConcept C2908647359 @default.
- W2776268962 hasConcept C3020491458 @default.
- W2776268962 hasConcept C512399662 @default.
- W2776268962 hasConcept C61511704 @default.
- W2776268962 hasConcept C71924100 @default.
- W2776268962 hasConcept C99454951 @default.
- W2776268962 hasConceptScore W2776268962C120665830 @default.
- W2776268962 hasConceptScore W2776268962C121332964 @default.
- W2776268962 hasConceptScore W2776268962C121608353 @default.
- W2776268962 hasConceptScore W2776268962C126322002 @default.
- W2776268962 hasConceptScore W2776268962C203014093 @default.
- W2776268962 hasConceptScore W2776268962C2522874641 @default.
- W2776268962 hasConceptScore W2776268962C2776231280 @default.
- W2776268962 hasConceptScore W2776268962C2777075537 @default.
- W2776268962 hasConceptScore W2776268962C2777214474 @default.
- W2776268962 hasConceptScore W2776268962C2777382497 @default.
- W2776268962 hasConceptScore W2776268962C2778527826 @default.
- W2776268962 hasConceptScore W2776268962C2779102576 @default.
- W2776268962 hasConceptScore W2776268962C2908647359 @default.
- W2776268962 hasConceptScore W2776268962C3020491458 @default.
- W2776268962 hasConceptScore W2776268962C512399662 @default.
- W2776268962 hasConceptScore W2776268962C61511704 @default.
- W2776268962 hasConceptScore W2776268962C71924100 @default.
- W2776268962 hasConceptScore W2776268962C99454951 @default.
- W2776268962 hasLocation W27762689621 @default.